Skip to content

Gastrointestinal stromal tumors: The histology report

by Angelo P. Dei Tos, Licia Laurino, Italo Bearzi, Luca Messerini, Fabio Farinati
Digestive and Liver Disease ()
Get full text at journal


Gastrointestinal stromal tumors (GISTs) represent a mesenchymal neoplasm occurring primarily in the gastrointestinal tract, and showing differentiation toward the interstitial cell of Cajal. Its incidence is approximately 15 case/100,000/year. Stomach and small bowel are the most frequently affected anatomic sites. GIST represents a morphological, immunophenotypical and molecular distinct entity, the recognition of which has profound therapeutic implications. In fact, they have shown an exquisite sensitivity to treatment with the tyrosine kinase inhibitor imatinib. Diagnosis relies upon morphology along with immunodetection of KIT and/or DOG1. When dealing with KIT negative cases, molecular analysis of KIT/PDGFRA genes may help in confirming diagnosis. Molecular evaluation of both genes are in any case recommended as mutational status provides key predictive information. Pathologists also play a key role in providing an estimation of the risk of biological aggressiveness, which is currently based on anatomic location of the tumor, size, and mitotic activity. ?? 2011 Editrice Gastroenterologica Italiana S.r.l.

Author-supplied keywords

Cite this document (BETA)

Readership Statistics

18 Readers on Mendeley
by Discipline
83% Medicine and Dentistry
17% Agricultural and Biological Sciences
by Academic Status
28% Other
28% Student > Doctoral Student
11% Researcher
by Country
6% Germany
6% France
6% Taiwan

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in